Login to Your Account

Inequitable Conduct Claim

Cubist Case Shanghai'd? Teva Launches Tricky New Strategy

By Randy Osborne

Monday, June 21, 2010
Last week's twist in the patent fight between Cubist Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. brought renewed attention to the worth of the case advanced by the latter, but it's not clear how the outcome of the battle would affect the ultimate fate of Cubist, which some bankers say is all but assured a takeover, and the only question is price.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription